These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6800027)

  • 41. [The preliminary experiences of diagnosis and treatment for hypercalcemia crisis--clinical analysis of 23 cases].
    Xing X; Meng X; Zhan Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Apr; 16(2):116-21. PubMed ID: 7987937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Narrative review: furosemide for hypercalcemia: an unproven yet common practice.
    LeGrand SB; Leskuski D; Zama I
    Ann Intern Med; 2008 Aug; 149(4):259-63. PubMed ID: 18711156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Therapeutic possibilities in paraneoplastic hypercalcemia].
    Schürer CC; Peters U; Fischer JT
    Med Welt; 1981 Aug; 32(32-33):1219-21. PubMed ID: 6456397
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical case records in chemotherapy: the management of hypercalcemia complicating cancer.
    Lenhard RE
    Cancer Chemother Rep; 1971 Nov; 55(4):509-21. PubMed ID: 4258277
    [No Abstract]   [Full Text] [Related]  

  • 45. [Biphosphonates in the treatment of osteolytic metastasis. Essential actions on hypercalcemia and important on lytic lesions].
    Liens D; Delmas PD
    Rev Prat; 1993 May; 43(10):1259-61. PubMed ID: 8235365
    [No Abstract]   [Full Text] [Related]  

  • 46. The emergency management of disorders of calcium and magnesium.
    Heath DA
    Clin Endocrinol Metab; 1980 Nov; 9(3):487-502. PubMed ID: 6452235
    [No Abstract]   [Full Text] [Related]  

  • 47. Pamidronate in the treatment of bone metastases--the European experience.
    Ford JF
    Br J Clin Pract Suppl; 1996 Sep; 87():3-4; discussion 13-4. PubMed ID: 8995009
    [No Abstract]   [Full Text] [Related]  

  • 48. A synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia.
    Shukeir N; Arakelian A; Chen G; Garde S; Ruiz M; Panchal C; Rabbani SA
    Cancer Res; 2004 Aug; 64(15):5370-7. PubMed ID: 15289344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pamidronate treatment for hypercalcemia in an infant receiving parenteral nutrition.
    Bryowsky JJ; Bugnitz MC; Hak EB
    Pharmacotherapy; 2004 Jul; 24(7):939-44. PubMed ID: 15303458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases.
    de Vernejoul MC
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):119S-123S. PubMed ID: 9273953
    [No Abstract]   [Full Text] [Related]  

  • 51. [PTHrP and breast cancer].
    Devys A; Lortholary A; Audran M
    Bull Cancer; 2001 Nov; 88(11):1075-80. PubMed ID: 11741801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful treatment of immobilization hypercalcemia using calcitonin and etidronate.
    Meythaler JM; Tuel SM; Cross LL
    Arch Phys Med Rehabil; 1993 Mar; 74(3):316-9. PubMed ID: 8439262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proceedings: Hypercalcemia in malignant bone diseases and its management. Studies on calcium metabolism and the use of calcitonin.
    Takatsuki K; Yodoi J; Wakisaka G; Yamamoto I; Hamamoto K
    Calcif Tissue Res; 1974; 15(2):157. PubMed ID: 4844394
    [No Abstract]   [Full Text] [Related]  

  • 54. Iatrogenic hypercalcaemia--a case report.
    Deshpande MM
    J Indian Med Assoc; 2009 Mar; 107(3):173. PubMed ID: 19810388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
    Clines GA; Guise TA
    Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recognition and management of hypercalcemia. A review.
    Mazzaferri EL; Cataland S
    Ohio State Med J; 1970 Nov; 66(11):1115-9. PubMed ID: 4990818
    [No Abstract]   [Full Text] [Related]  

  • 57. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
    Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Synthetic salmon calcitonin in the therapeutic management of osteolytic metastases of breast carcinoma].
    Simone C; Racanelli A
    Clin Ter; 1981 Aug; 98(3):247-67. PubMed ID: 7285537
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of hypercalcemia and hyperkalemia.
    Coniglione TC
    Med Times; 1978 Jul; 106(7):69-75. PubMed ID: 672557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.